DAWN P/E Ratio
P/E Ratio as of Jun 13, 2025: -9.97
Average-9.90
Median-9.84
Minimum-10.75
Maximum-9.21
-9.97
Past Month-0.72 (7.78%)
The P/E ratio for DAWN is -9.97 as of Jun 13, 2025. This represents a increase of 4.73% compared to its 12-month average P/E ratio of -9.52. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Day One Biopharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Day One Biopharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Day One Biopharmaceuticals to industry peers.
Day One Biopharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Day One Biopharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Day One Biopharmaceuticals to industry peers.
DAWN P/E Ratio Insights
See Day One Biopharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in DAWN
Order type
Buy in
Order amount
Est. shares
0 shares
DAWN P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $7.01 | -10.48 |
| May 1, 2025 | $7.62 | -7.34 |
| Apr 1, 2025 | $7.61 | -7.33 |
| Mar 3, 2025 | $8.25 | -7.94 |
| Feb 3, 2025 | $12.07 | -11.91 |
| Jan 2, 2025 | $12.71 | -12.54 |
DAWN End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -9.97 | -20.24% |
| 2024 | -12.50 | +95.62% |
| 2023 | -6.39 | -41.70% |
| 2022 | -10.96 | +79.08% |
| 2021 | -6.12 | — |
FAQs About Day One Biopharmaceuticals (DAWN) P/E ratio
The latest P/E ratio of DAWN is -9.97, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Day One Biopharmaceuticals’s last 12-month average P/E ratio is -9.52, compared to its current P/E ratio of -9.97. This reflects a increase of 4.73%.
Day One Biopharmaceuticals’s current P/E ratio of -9.97 is higher than its last 12-month average P/E of -9.52. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Day One Biopharmaceuticals’s average P/E ratio over the last 3 years is -8.29. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Day One Biopharmaceuticals’s average P/E ratio over the last 5 years is -5.5. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.